Evidence map›Paper›PMID 28018913›Full record

ArticleBioMed research international2016

Evolution of

Dong Yu, Zhiqiu Yin, Yuan Jin, Jing Zhou, Hongguang Ren, Mingda Hu, Beiping Li, Wei Zhou, Long Liang, Junjie Yue

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. EnteropathogenicMicroorganisms · 2024
    Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Dong YuBeijing Institute of Biotechnology, Beijing, China; The Second Military Medical University, Shanghai, China.
Zhiqiu YinBeijing Institute of Biotechnology, Beijing, China; Anhui University, Hefei, Anhui, China.
Yuan JinBeijing Institute of Biotechnology, Beijing, China.
Jing ZhouBeijing Institute of Biotechnology, Beijing, China.
Hongguang RenBeijing Institute of Biotechnology, Beijing, China.
Mingda HuBeijing Institute of Biotechnology, Beijing, China.
Beiping LiBeijing Institute of Biotechnology, Beijing, China.
Wei ZhouBeijing Institute of Biotechnology, Beijing, China.
Long LiangBeijing Institute of Biotechnology, Beijing, China.ORCID 0000-0002-0290-261X
Junjie YueBeijing Institute of Biotechnology, Beijing, China.ORCID 0000-0002-2549-9261
Anhui University · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy is an important defense mechanism targeting intracellular bacteria to restrict their survival and growth. On the other hand, several intracellular pathogens have developed an antiautophagy mechanism to facilitate their own replication or intracellular survival. Up to now, no information about the origin or evolution of the antiautophagic genes in bacteria is available. BopA is an effector protein secreted by

Indexed as

AutophagyBacterial ProteinsBase CompositionBurkholderia pseudomalleiEvolution, MolecularGene Transfer, HorizontalHost-Pathogen InteractionsHumansImmune EvasionPhylogenyBacterial Proteins

Identifiers

PMID28018913
PMCPMC5149610
OpenAlexW2555671960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.